Results 1 to 10 of about 30,931 (159)

The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes [PDF]

open access: yesFrontiers in Endocrinology, 2018
Calcitonin (CT)/CT gene-related peptide (CGRP) family peptides (CT/CGRP family peptides) including CT, CGRP, adrenomedullin, amylin, and CT receptor-stimulating peptide have been identified from various vertebrates and perform a variety of important ...
Toshio Sekiguchi
doaj   +3 more sources

Safety and efficacy of calcitonin gene-related peptide antagonists for cluster headache: a systematic review and meta-analysis [PDF]

open access: yesBMC Neurology
Background Calcitonin gene-related peptide is an emerging therapeutic target in cluster headache, yet evidence on the preventive efficacy and safety of calcitonin gene-related peptide antagonists remains limited.
Ro’ya Khanfar   +2 more
doaj   +2 more sources

Research Progress in Calcitonin Gene-Related Peptide and Bone Repair

open access: yesBiomolecules, 2023
Calcitonin gene-related peptide (CGRP) has 37 amino acids. Initially, CGRP had vasodilatory and nociceptive effects. As research progressed, evidence revealed that the peripheral nervous system is closely associated with bone metabolism, osteogenesis ...
Qichang Wang   +6 more
doaj   +3 more sources

Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis. [PDF]

open access: yesPLoS ONE, 2014
This study examined whether mice with a deficiency of neurofibromin, a Ras GTPase activating protein, exhibit a nociceptive phenotype and probed a possible contribution by calcitonin gene-related peptide.
Stephanie White   +3 more
doaj   +1 more source

Calcitonin gene-related peptide causes migraine aura

open access: yesThe Journal of Headache and Pain, 2023
Background Although the involvement of calcitonin gene-related peptide (CGRP) in migraines is well-established, its specific role in investigating the aura phase, which often precedes the headache, remains largely unexplored. This study aims to instigate
Haidar M. Al-Khazali   +8 more
doaj   +1 more source

Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin [PDF]

open access: yesBiochemical Journal, 1991
Near-u.v. and far-u.v. c.d. spectra of human alpha-calcitonin-gene-related peptide (h alpha CGRP), analogues and fragments of CGRP and amylin were recorded in aqueous solution and in trifluoroethanol (TFE)/water mixtures. All peptides contained significant amounts of alpha-helix in aqueous solution, and this amount increased on adding TFE.
J A, Hubbard   +5 more
openaire   +2 more sources

Improved osteoarthritis during erenumab treatment for migraine: a case report

open access: yesCase Reports in Neurology, 2023
Antibodies blocking the calcitonin gene-related peptide have revolutionized episodic and chronic migraine treatment. However, their applicability to non-cephalic pain conditions, such as osteoarthritis is yet unknown.
Frederik Thal Jantzen   +3 more
doaj   +1 more source

Correlation between CGRP Levels and the Neuropathic and Inflammatory Component of Postoperative Pain [PDF]

open access: yesFolia Medica, 2020
Introduction: In surgical procedures, tissue damage results in the release of a number of bioactive substances. Calcitonin gene-related peptide (CGRP) is a peptide released from sensory nerves, which determines its role in pain sensation.
Deyan Neychev   +5 more
doaj   +3 more sources

Calcitonin Gene-Related Peptide in Charcot Foot Neuroarthropathy

open access: yesFoot & Ankle Orthopaedics, 2022
Category: Basic Sciences/Biologics; Diabetes Introduction/Purpose: Charcot neuroarthropathy (CNA) is a destructive joint condition secondary to neuropathic deficiency.
Yi Guo   +5 more
doaj   +1 more source

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

open access: yesThe Journal of Headache and Pain, 2019
Background and aim Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor ...
Simona Sacco   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy